Medscape

FDA Safety Labeling Changes: Lovenox, Nutropin Depot, Roferon-A

Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...
Yahoo Finance

PharmaJet®, a World Leader in Needle-Free Injection Systems, is Initiating the Development of Needle-Free Self-Injection Pens for Home Use

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...
Reuters

Sanofi wins FDA approval for wider use of Lovenox

PARIS, May 18 (Reuters) - Sanofi-Aventis has won U.S. health authority clearance to use its bloodthinner Lovenox in patients who suffer from the most severe type of heart attack, the French drugmaker ...
Yahoo Finance

PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference

PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...